peresolimab
eli lilly
['peresolimab', 'imab ']
peresolimab humanized igg1 mab stimulates pd-1 &amp; physiological immune inhibitory pathways in ra phase 2 study, superior to placebo at week 12 das28/cdai safety events were similar between treatment groups emery p #l03 #acr22 #acrbest 
MD PhD Consultant Rheumatologist &Physician,Assoc Medical Director,Digital Leader,NASS Trustee &Best Rheum Care,Visiting Fellow Henley Business School,ExecCoach